NDAINTRAVENOUSSOLUTION1 Generic Approved
Approved
May 2021
Lifecycle
Peak
Competitive Pressure
15/100
Clinical Trials
3
Data completeness
4/8 — Partial
Drug data last refreshed 4h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Levothyroxine sodium is a synthetic thyroid hormone replacement therapy administered intravenously as a solution formulation. It is used to treat hypothyroidism and other thyroid hormone deficiency conditions. The drug works by supplementing or replacing endogenous thyroid hormone to restore normal metabolic function.
Peak10.1 years to LOE
IV levothyroxine operates in peak lifecycle stage with moderate competitive pressure (15 competitors), suggesting stable team sizes and mature commercial infrastructure.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (3)
Bioequivalence of Two Formulations of Levothyroxine Sodium 200 Micrograms (mcg) Under Tablet Form
Started Jun 2019
72 enrolled
Healthy
Levothyroxine Sodium in Thyroidectomized Patients Taking Proton Pump Inhibitors
Started Jul 2018
66 enrolled
Hypothyroidism;Postablative
Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation
Started Jul 2013
101 enrolled
Hypothyroidism
Career Relevance
Levothyroxine sodium offers stable, mature-stage career opportunities in a well-established therapeutic class with predictable market dynamics and limited scientific innovation. Working on this product positions professionals in commercial excellence and market management roles rather than cutting-edge clinical or discovery work.
Worked on LEVOTHYROXINE SODIUM at Hikma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.